Search results

Evidence-based recommendations on bevacizumab (Avastin), with other drugs, for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

15 December 2010

Evidence-based recommendations on aflibercept (Zaltrap) with irinotecan and fluorouracil-based therapy (FOLFIRI) for treating metastatic colorectal cancer after oxaliplatin-based chemotherapy in adults.

Result type

Technology appraisal guidance

Published

25 March 2014

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the

Result type

Diagnostics guidance

Published

10 December 2014

Evidence-based recommendations on capecitabine for treating advanced gastric cancer in adults.

Result type

Technology appraisal guidance

Published

28 July 2010

Evidence-based recommendations on trastuzumab (Herceptin) for treating HER2-positive metastatic gastric cancer in adults.

Result type

Technology appraisal guidance

Published

24 November 2010

In development [GID-TA11228] Expected publication date: 11 June 2025

Result type

Technology appraisal guidance

Status

In development

This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support. It aims to reduce variation in practice through better organisation of care and support, and improve quality of life and survival by giving advice on the most suitable treatments depending on cancer type, stage and location.

Result type

NICE guideline

Last updated

4 July 2023

Evidence-based recommendations on capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer in adults.

Result type

Technology appraisal guidance

Published

26 April 2006

Evidence-based recommendations on ivosidenib (Tibsovo) for treating locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation in adults after 1 or more systemic treatments.

Result type

Technology appraisal guidance

Published

31 January 2024

In development [GID-TA10165] Expected publication date: TBC

Result type

Technology appraisal guidance

Status

In development

Evidence-based recommendations on pembrolizumab (Keytruda) with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer in adults.

Result type

Technology appraisal guidance

Last updated

29 August 2024

Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

8 February 2023

Evidence-based recommendations on cetuximab (Erbitux), bevacizumab (Avastin) and panitumumab (Vectibix) for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

25 January 2012

precision of the My5-FU assay for the quantitative determination of 5-fluorouracil (5-FU) at the lower end of its measuring range with...

Result type

Research recommendation

Published

9 June 2015

Evidence-based recommendations on nivolumab (Opdivo) with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma in adults.

Result type

Technology appraisal guidance

Published

11 January 2023